205 related articles for article (PubMed ID: 24833526)
1. SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.
Müller S; Chen Y; Ginter T; Schäfer C; Buchwald M; Schmitz LM; Klitzsch J; Schütz A; Haitel A; Schmid K; Moriggl R; Kenner L; Friedrich K; Haan C; Petersen I; Heinzel T; Krämer OH
Oncotarget; 2014 May; 5(10):3184-96. PubMed ID: 24833526
[TBL] [Abstract][Full Text] [Related]
2. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA
PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787
[TBL] [Abstract][Full Text] [Related]
3. HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3.
Mahendrarajah N; Borisova ME; Reichardt S; Godmann M; Sellmer A; Mahboobi S; Haitel A; Schmid K; Kenner L; Heinzel T; Beli P; Krämer OH
Cell Signal; 2017 Nov; 39():9-17. PubMed ID: 28739485
[TBL] [Abstract][Full Text] [Related]
4. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
6. A novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells.
Carmo CR; Lyons-Lewis J; Seckl MJ; Costa-Pereira AP
PLoS One; 2011; 6(5):e19861. PubMed ID: 21625473
[TBL] [Abstract][Full Text] [Related]
7. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
[TBL] [Abstract][Full Text] [Related]
8. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.
Peng HY; Cheng YC; Hsu YM; Wu GH; Kuo CC; Liou JP; Chang JY; Jin SL; Shiah SG
PLoS One; 2016; 11(7):e0158440. PubMed ID: 27367272
[TBL] [Abstract][Full Text] [Related]
9. Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling.
Liu H; Wang M; Liang N; Guan L
Turk J Gastroenterol; 2019 Aug; 30(8):722-731. PubMed ID: 31418417
[TBL] [Abstract][Full Text] [Related]
10. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
Wan J; Fu AK; Ip FC; Ng HK; Hugon J; Page G; Wang JH; Lai KO; Wu Z; Ip NY
J Neurosci; 2010 May; 30(20):6873-81. PubMed ID: 20484629
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
12. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
Looyenga BD; Hutchings D; Cherni I; Kingsley C; Weiss GJ; Mackeigan JP
PLoS One; 2012; 7(2):e30820. PubMed ID: 22319590
[TBL] [Abstract][Full Text] [Related]
13. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
Liu A; Liu Y; Li PK; Li C; Lin J
Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
[TBL] [Abstract][Full Text] [Related]
14. Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2.
Yang Z; Xiang Q; Nicholas J
PLoS Pathog; 2023 Nov; 19(11):e1011806. PubMed ID: 37983265
[TBL] [Abstract][Full Text] [Related]
15. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin signal transduction requires functional JAK2, not TYK2.
Drachman JG; Millett KM; Kaushansky K
J Biol Chem; 1999 May; 274(19):13480-4. PubMed ID: 10224114
[TBL] [Abstract][Full Text] [Related]
17. Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Pérez M; García-Limones C; Zapico I; Marina A; Schmitz ML; Muñoz E; Calzado MA
J Mol Cell Biol; 2012 Oct; 4(5):316-30. PubMed ID: 22878263
[TBL] [Abstract][Full Text] [Related]
18. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
[TBL] [Abstract][Full Text] [Related]
20. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G
Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
